Loracarbef is an antibiotic. It is a carbacephem, but it is sometimes grouped together with the second-generation cephalosporin antibiotics. Loracarbef is a synthetic "carba" analogue of cefaclor, and is more stable chemically. Loracarbef received FDA approval in 1991 and it was marketed under the trade name Lorabid. References: Balatsouras DG, Korres S, Rallis E, Eliopoulos P, Ferekidis E. Twice-daily dosing of loracarbef 15 mg/kg versus 30 mg/kg in the treatment of children with acute sinusitis. Drugs Exp Clin Res. 2005;31 Suppl:1-5. PubMed PMID: 16444905.

纯度：≥98%

CAS：76470-66-1